Treatment of rectal chlamydia infection may be more complicated than we originally thought
Open Access
- 4 December 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 70 (4) , 961-964
Abstract
Rectal chlamydia diagnoses have been increasing among MSM and may also rise among women as anal sex rates increase among heterosexuals. However, there is growing concern about treatment for rectal chlamydia with treatment failures of up to 22% being reported. This article addresses factors that may be contributing to treatment failure for rectal chlamydia, including the pharmacokinetic properties of azithromycin and doxycycline in rectal tissue, the ability of chlamydia to transform into a persistent state that is less responsive to antimicrobial therapy, the impact of the rectal microbiome on chlamydia, heterotypic resistance, failure to detect cases of lymphogranuloma venereum and the performance of screening tests. If we are to reduce the burden of genital chlamydia, treatment for rectal chlamydia must be efficacious. This highlights the need for randomized controlled trial evidence comparing azithromycin with doxycycline for the treatment of rectal chlamydia.Keywords
This publication has 29 references indexed in Scilit:
- Detection of Anorectal and Cervicovaginal Chlamydia Trachomatis Infections following Azithromycin Treatment: Prospective Cohort Study with Multiple Time-Sequential Measures of rRNA, DNA, Quantitative Load and SymptomsPLOS ONE, 2013
- Lymphogranuloma Venereum in Men Screened for Pharyngeal and Rectal Infection, GermanyEmerging Infectious Diseases, 2013
- Anorectal and inguinal lymphogranuloma venereum among men who have sex with men in Amsterdam, the Netherlands: trends over time, symptomatology and concurrent infectionsSexually Transmitted Infections, 2013
- The prevalence of Chlamydia trachomatis infection in Australia: a systematic review and meta-analysisBMC Infectious Diseases, 2012
- Azithromycin antimicrobial resistance and genitalChlamydia trachomatisinfection: duration of therapy may be the key to improving efficacySexually Transmitted Infections, 2012
- Effects of antibiotics on Chlamydia trachomatis viability as determined by real-time quantitative PCRJournal of Medical Microbiology, 2011
- Rectal chlamydia--a reservoir of undiagnosed infection in men who have sex with menSexually Transmitted Infections, 2009
- Electron microscopic evidence of persistent chlamydial infection following treatmentJournal of the European Academy of Dermatology and Venereology, 2001
- Azithromycin Clinical PharmacokineticsClinical Pharmacokinetics, 1993
- Gynaecological tissue levels of azithromycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991